The indictment alleges that between March 2021 and February 2023, Dr. Pettyjohn, 77, and Ms. Gallagher, 34, collaborated to sponsor patients at Dr. Pettyjohn’s clinic and ordered controlled substances for Ms. Gallagher herself and others with no legitimate medical purpose, which Ms. Gallagher then abused and distributed to others, according to a Nov. 7 news release from the Justice Department.
Also, in July 2020, Dr. Pettyjohn was restricted by Florida’s Board of Osteopathic Medicine from prescribing opioids due to complaints about the manner in which she prescribed them. After the restriction took effect, Dr. Pettyjohn continued to prescribe opioids in violation of the order.
If convicted, Dr. Pettyjohn and Ms. Gallagher each faces a maximum penalty of 20 years in federal prison on each count, according to the release.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.